Cardiotoxicity Following Cancer Treatment
- PMID: 28298705
- PMCID: PMC5324172
Cardiotoxicity Following Cancer Treatment
Abstract
More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the heart. As the oncologist's focus begins to encompass the issues of cancer survivorship, awareness of the management of cardiac toxicity would be prudent for all physicians looking after patients with cancer.
Figures
References
-
- Cancer Research UK . About radiotherapy. [Internet] London: Cancer Research UK; 2014. [Updated 2014; cited 2015]. Available online: http://www.cancerresearchuk.org/about-cancer/cancers-in-general/treatmen... Last accessed September 2016.
-
- Stewart JR, Fajardo LF. Radiation-induced heart disease: an update. Prog Cardiovasc Dis. 1984;27(3):173–94. - PubMed
-
- NICE Clinical Guideline 121. [Internet] London: National Institute of Clinical Excellence; 2005. [Updated 2011; cited 2015]. Available online from: https://www.nice.org.uk/guidance/cg121. Last accessed March 2016.
-
- Cancer Research UK . Lung cancer incidence statistics. [Internet] London: National Institute of Clinical Excellence; 2005. [Updated 2011; cited 2015]. Available online from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/st.... Last accessed March 2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials